Gr Sarantis SA
ATHEX:SAR
| US |
|
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
| US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
| US |
|
Bank of America Corp
NYSE:BAC
|
Banking
|
| US |
|
Mastercard Inc
NYSE:MA
|
Technology
|
| US |
|
UnitedHealth Group Inc
NYSE:UNH
|
Health Care
|
| US |
|
Exxon Mobil Corp
NYSE:XOM
|
Energy
|
| US |
|
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
| US |
|
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
| US |
|
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
| US |
|
Visa Inc
NYSE:V
|
Technology
|
| CN |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
| US |
|
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
| US |
|
Coca-Cola Co
NYSE:KO
|
Beverages
|
| US |
|
Walmart Inc
NYSE:WMT
|
Retail
|
| US |
|
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
| US |
|
Chevron Corp
NYSE:CVX
|
Energy
|
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
10.72
15
|
| Price Target |
|
We'll email you a reminder when the closing price reaches EUR.
Choose the stock you wish to monitor with a price alert.
|
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
|
Bank of America Corp
NYSE:BAC
|
US |
|
|
Mastercard Inc
NYSE:MA
|
US |
|
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
|
Pfizer Inc
NYSE:PFE
|
US |
|
|
Palantir Technologies Inc
NYSE:PLTR
|
US |
|
|
Nike Inc
NYSE:NKE
|
US |
|
|
Visa Inc
NYSE:V
|
US |
|
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
|
Coca-Cola Co
NYSE:KO
|
US |
|
|
Walmart Inc
NYSE:WMT
|
US |
|
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
|
Chevron Corp
NYSE:CVX
|
US |
This alert will be permanently deleted.
Gr Sarantis SA
GR Sarantis SA engages in the trade and production of consumer products. The company is headquartered in Athina, Attiki and currently employs 2,186 full-time employees. Its product portfolio includes Fragrances and Cosmetics, like aftershave lotions and deodorants with brands such as Adidas and C-THRU; household products, like food packaging, cleaning and shoe care products of such brands as Sanitas and Camel and health and care products, which mainly comprise vitamins and food supplements. The firm has also formed joint-ventures and strategic alliances with international companies in the cosmetics, health and beauty sectors, such as Estee Lauder, Kolastyna, Domet, Topstar and Clinique, for exclusive distribution of their products in Greece and Eastern Europe. The Company’s subsidiaries include SARANTIS PORTUGAL, ASTRID S.R.O. and Polipak Sp. z.o.o.
GR Sarantis SA engages in the trade and production of consumer products. The company is headquartered in Athina, Attiki and currently employs 2,186 full-time employees. Its product portfolio includes Fragrances and Cosmetics, like aftershave lotions and deodorants with brands such as Adidas and C-THRU; household products, like food packaging, cleaning and shoe care products of such brands as Sanitas and Camel and health and care products, which mainly comprise vitamins and food supplements. The firm has also formed joint-ventures and strategic alliances with international companies in the cosmetics, health and beauty sectors, such as Estee Lauder, Kolastyna, Domet, Topstar and Clinique, for exclusive distribution of their products in Greece and Eastern Europe. The Company’s subsidiaries include SARANTIS PORTUGAL, ASTRID S.R.O. and Polipak Sp. z.o.o.
Modest Sales Growth: Net sales for the first half of 2025 grew marginally year-over-year (+0.5%), as the group lapped a very strong prior year period.
Profitability Surge: EBITDA rose nearly 16% to EUR 48.3 million, with double-digit growth also seen in EBIT, EBT, and net income, driven by a favorable product mix, operational efficiency, and cost control.
Margin Expansion: Gross profit margin held steady at 38.6%, while EBITDA margin increased by 200 basis points to 15.9%, and EBIT margin rose by 181 basis points to 12.3%.
Beauty & Sun Care Strength: Beauty, Skin and Sun Care category sales jumped 22.7% to EUR 55 million, significantly improving margins and offsetting declines in other segments.
International Expansion: Exports, especially to the U.S. and new launches in Australia and the Middle East, drove strong growth; export EBIT margin reached 41%.
Private Label Decline: Private label sales dropped 16.7% due to portfolio rationalization but had limited impact on overall profitability due to lower margins.
CapEx and Digital Investments: CapEx for 2025 was revised down to EUR 34.5 million; digital transformation and factory upgrades remain on track.
2025 Guidance Reiterated: Full-year 2025 guidance was reaffirmed: net sales expected to reach EUR 612 million (+2% YoY), EBITDA EUR 92 million (+12.7% YoY), and EBIT EUR 70 million (+3% YoY).
